Filing Flows › Kestra Medical Technologies (KMTS) › Q4 FY25
Kestra Medical Technologies (KMTS) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Jul 17, 2025
Kestra Medical Technologies (KMTS) reported revenue of $17.2M for the fourth quarter fiscal 2025 (Q4 FY25) and +14% from the quarter before. Operating margin was -279.8%, net loss $51.1M (296.6% of revenue).
Kestra Medical Technologies, Q4 FY25: revenue $17.2M, operating margin -279.8%, net loss $51.1M, operating cash flow −$24.1M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.2M | +14% | — |
| Operating profit | −$48.2M | — | — |
| Net earnings | −$51.1M | — | — |
| Operating cash flow | −$24.1M | — | — |
What changed
Revenue was $17.2M in Q4 FY25, up 14% from the previous quarter.
Gross margin was 44.3%. Operating costs exceeded revenue by $48.2M, an operating margin of -279.8%. The quarter ended with a net loss of $51.1M, wider than the previous quarter's $21.8M loss.
Operating cash flow was −$24.1M. Non-cash charges added back $1.8M of depreciation and $22.3M of share-based compensation. Working capital and other items added $2.9M. Capital expenditures of $7.4M exceeded it, leaving free cash flow of −$31.4M.
Questions
What was Kestra Medical Technologies' revenue in the fourth quarter fiscal 2025?
Kestra Medical Technologies (KMTS) reported revenue of $17.2M for the fourth quarter fiscal 2025 (Q4 FY25) and +14% from the quarter before.
Was Kestra Medical Technologies profitable in the fourth quarter fiscal 2025?
Operating loss was $48.2M (-279.8% of revenue) and net loss $51.1M.